Filing Details
- Accession Number:
- 0001209191-22-041230
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-06 17:02:46
- Reporting Period:
- 2022-07-01
- Accepted Time:
- 2022-07-06 17:02:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1671026 | Sanjay Shukla | 3545 John Hopkins Court, Suite #250 San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-01 | 15,000 | $2.88 | 40,798 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.86 to $2.89 per share. The reportingperson will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, fullinformation regarding the number of shares purchased at each separate price
Billionaire Hedge Funds
